Autor/in Aalders, K 1 Brain, E 1 Fasching, P 1 Fehm, T Forstbauer, H 1 Ignatiadis, M 1 Litière, S 1 Proudhon, C Riethdorf, S 1 Rothe, F 1 Vuylsteke, P alle zeigenListe einklappen
Trastuzumab versus observation for HER2 non amplified early breast cancer with Circulating Tumor Cells (EORTC 90091-10093, BIG 1-12, Treat CTC): A randomized phase 2 trial Ignatiadis, M Litière, S Rothe, F Riethdorf, S Proudhon, C Fehm, T Aalders, K 2018 - Forschungsinformationssystem des UKE
